Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis

European Journal of Endocrinology

Volumn 161, Issue 2, 2009, Pages 339-344

  Lehrke, Michael ^a   Becker, Alexander ^a   Greif, Martin ^a   Stark, Renee ^b   Laubender, Rüdiger P ^c   Von Ziegler, Franz ^a   Lebherz, Corinna ^a   Tittus, Janine ^a   Reiser, Maximilian ^c   Becker, Christoph ^c   Göke, Burkhard ^a   Leber, Alexander W ^a   Parhofer, Klaus G ^a   Broedl, Uli C ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; CHEMERIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LEPTIN; RESISTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CHEMERIN, HUMAN; CHEMOKINE; CHOLESTEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; THORAX PAIN; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; COHORT ANALYSIS; CORONARY ARTERY DISEASE; IMMUNOLOGY; METABOLISM; MIDDLE AGED; REGRESSION ANALYSIS;

AGED; C-REACTIVE PROTEIN; CHEMOKINES; CHOLESTEROL; COHORT STUDIES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION; INTERLEUKIN-6; LEPTIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; REGRESSION ANALYSIS; RESISTIN; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 68349146816     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0380     Document Type: Article

References (18)

1. Rajala MW & Scherer PE. Minireview: the adipocyte - at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003 144 3765-3773.
2. Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Migeotte I, Brézillon S, Tyldesley R, Blanpain C, Detheux M, Mantovani A, Sozzani S, Vassart G, Parmentier M & Communi D. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. Journal of Experimental Medicine 2003 198 977-985. (Pubitemid 37248614)
3. Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, Walder K & Segal D. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007 148 4687-4694. (Pubitemid 47481514)
4. Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, Parlee SD, Muruganandan S & Sinal CJ. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. Journal of Biological Chemistry 2007 282 28175-28188. (Pubitemid 47529521)
5. Cash JL, Hart R, Russ A, Dixon JP, Colledge WH, Doran J, Hendrick AG, Carlton MB & Greaves DR. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. Journal of Experimental Medicine 2008 205 767-775. (Pubitemid 351549876)
6. Barnea G, Strapps W, Herrada G, Berman Y, Ong J, Kloss B, Axel R & Lee KJ. From the cover: the genetic design of signaling cascades to record receptor activation. PNAS 2008 105 64-69.
7. Zabel BA, Nakae S, Zúñiga L, Kim JY, Ohyama T, Alt C, Pan J, Suto H, Soler D, Allen SJ, Handel TM, Song CH, Galli SJ & Butcher EC. Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. Journal of Experimental Medicine 2008 205 2207-2220.
8. Yoshimura T & Oppenheim JJ. Chemerin reveals its chimeric nature. Journal of Experimental Medicine 2008 205 2187-2190.
9. Wittamer V, Bondue B, Guillabert A, Vassart G, Parmentier M & Communi D. Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity. Journal of Immunology 2005 175 487-493. (Pubitemid 40884353)
10. Takahashi M, Takahashi Y, Takahashi K, Zolotaryov FN, Hong KS, Kitazawa R, Iida K, Okimura Y, Kaji H, Kitazawa S, Kasuga M & Chihara K. Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Letters 2008 582 573-578.
11. Broedl UC, Lebherz C, Lehrke M, Stark R, Greif M, Becker A, von Ziegler F, Tittus J, Reiser M, Becker C, Göke B, Parhofer KG & Leber AW. Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques. PLoS ONE 2009 4 e4733.
12. Greif M, Becker A, von Ziegler F, Lebherz C, Lehrke M, Broedl U, Tittus J, Parhofer K, Becker C, Reiser M, Knez A & Leber AW. Pericardial adipose tissue determined by dual source CT is a risk factor for coronary atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 781-786.
13. Tedgui A & Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiological Reviews 2006 86 515-581.
14. Gualillo O, González-Juanatey JR & Lago F. The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives. Trends in Cardiovascular Medicine 2007 17 275-283. (Pubitemid 350087698)
15. Reilly MP, Iqbal N, Schutta M, Wolfe ML, Scally M, Localio AR, Rader DJ & Kimmel SE. Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2004 89 3872-3878. (Pubitemid 39071487)
16. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA & Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005 111 932-939. (Pubitemid 40279897)
17. Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. American Journal of Cardiology 2006 97 3A-11A.
18. Ridker PM, Hennekens CH, Buring JE & Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New England Journal of Medicine 2000 342 836-843. (Pubitemid 30165206)